botulinum toxin type A inhibitor

This page covers all botulinum toxin type A inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting botulinum toxin type A.

Targets

botulinum toxin type A

Phase 3 pipeline (4)

• DWC202404, DWC202314P · Daewoong Pharmaceutical Co. LTD. · Neurology
  DWC202404 is a botulinum toxin type A inhibitor.
• DWC202313, DWC202314 · Daewoong Pharmaceutical Co. LTD. · Neurology
  DWC202313 and DWC202314 are botulinum toxin type A inhibitors.
• DWC202405, DWC202314P · Daewoong Pharmaceutical Co. LTD. · Neurology
  DWC202405 is a botulinum toxin type A inhibitor.
• DWC202313, DWC202314P · Daewoong Pharmaceutical Co. LTD. · Neurology
  DWC202313 and DWC202314P are botulinum toxin type A inhibitors.